使用兩種“自動友好的”產品能夠為樣本跟蹤和實驗室分類提供完全徹底的解決方案，而且能夠減少誤差并增加效率。

第一種產品在96孔板上含有埃希氏菌屬大腸桿菌菌株作為化學成分，已經明確可以作為自動化。每塊板具有獨有的條帶編碼，包括培養板的部分編號、批號編碼以及這塊板的唯一的區別號碼。這就能夠很容易的在NextGen科學公司的orchestratorIMS數據庫中詳細記錄這些孔的數據，正是這家公司研發了這種產品。

OrchestratorIMS是一種信息控制系統，整合了基因處理軟件和樣品、試劑跟蹤數據庫以及自動基因克隆和蛋白質表達機器平臺。這套軟件提供了虛擬設計和表達產物之間的無逢鏈接，使得研究人員能夠計劃、協調、執行、監測以及跟蹤克隆與表達過程。NextGen的表達工廠和表達工作平臺可以整合orchestratorIMS，能夠允許數據在自動機器與數據庫之間進行實時交換，用于協調的操作。

NextGen科學公司的Kevin Auton博士說：“在收到孔板之后，一次簡單的條帶編碼掃描即可將這些孔所包含的所有信息輸入orchestratorIMS之中，允許操作者能夠建立和記錄所有類型孔的信息以及貯存地點和應用情況。”
 
New Automation-Friendly Products
 
The launch of two new consumable products that are “automation friendly” is designed to provide a complete solution for sample tracking and laboratory cataloguing while reducing errors and increasing expression effectiveness.

The first product includes high efficiency Escherichia coli strains as chemically competent cells in 96 well plates, which have been validated for automation. Each plate has a unique barcode that includes the plate’s part number, batch number, and a unique identifier for the plate. This makes it easy to inventory the cells within the orchestratorIMS database of NextGen Sciences (Huntingdon, UK), which developed these new products.

OrchestratorIMS is an information-management system that integrates gene manipulation software and a sample- and reagents-tracking database with robotic platforms for automated gene cloning and protein expression. The software provides a seamless link between the process of designing an expression construct virtually and their development and expression in the laboratory, enabling researchers to plan, coordinate, execute, monitor, and track cloning and expression strategies. NextGen’s expressionfactory and expressionworkstation platforms are integrated into the orchestratorIMS, enabling data to be exchanged in real time between the robotics and the database for truly orchestrated operations.

“Upon receipt of the competent cells, a simple barcode scan will enter all of the information about the cells into orchestratorIMS, instantly enabling the user to create an inventory, recording the type of cells, their storage locations, and availability,” said Dr. Kevin Auton, CEO of NextGen Sciences.